MEN 2A con doble mutación en gen RET: carcinoma medular de tiroides secretor de ACTH

Ares, Jessica; Díaz Naya, Lucía; Martín Nieto, Alicia; Pertierra, Joaquín.
Med. clín (Ed. impr.) ; 146(9): 419-420, mayo 2016.
Artículo en Español | IBECS (España) | ID: ibc-151658

Documentos relacionados

  1. RET gene mutational diagnosis and precision medicine in Mexico.
  2. Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results.
  3. Multiple endocrine neoplasia type 2 (MEN2) and RET specific modifications of the ACMG/AMP variant classification guidelines and impact on the MEN2 RET database.
  4. Diagnostic RET genetic testing in 1,058 index patients: A UK centre perspective.
  5. Two sisters diagnosed with familial paraganglioma syndrome type 1 (FPGL1) and multiple endocrine neoplasia type 2A (MEN2A).
  6. [The trends in early precision diagnosis and treatment strategies of multiple endocrine neoplasia type 2].
  7. [Surgical aspects of multiple endocrine neoplasia type 2].
  8. [Multiple endocrine neoplasia type 2].
  9. [Clinical manifestations, therapeutic response to tyrosinase inhibitor and RET gene activating mutation in a patient with multiple endocrine neoplasia 2B].
  10. Patient quality of life and prognosis in multiple endocrine neoplasia type 2.